Sellas Life Sciences remains a 'Strong Sell,' as the REGAL trial delay signals increased risk of failure and diminished ...

Boost ROI with validated AI, specialized vendors and diversified delivery—strengthening compliance, resilience, data quality and speed across the life sciences lifecycle.Dublin, Oct. (GLOBE NEWSWIRE) ...

GT Metabolic Solutions has secured a Series C growth investment from J.P. Morgan Life Sciences Private Capital to accelerate ...

The next major breakthrough in life sciences may have a company’s name attached to it, but increasingly, the story behind ...

SELLAS Life Sciences Group Inc SLS shares are falling Wednesday, pulling back after trading higher earlier in the day, as the ...

ELIQUENT Life Sciences, a global regulatory, quality and safety consulting firm, today announced its participation in ExoCordOA, a €13 million, five-year project funded by Horizon Europe and ...

Breaking news and analysis of biotech, life sciences and other emerging technologies and research impacting health and well-being.

The Rhode Island Life Science Hub isn't a building or a lab — it's a quasi-public organization that helps researchers and ...

In the post-pandemic world, the life sciences are taking centre stage. From Boston’s Kendall Square to Singapore’s Biopolis, innovation districts that focus on the life sciences have the potential to ...

Shares of SELLAS Life Sciences Group, Inc. ( SLS) are falling 17 percent on Wednesday morning after the company announced that the pivotal Phase 3 REGAL trial evaluating galinpepimut-S in patients ...

Anthropic plans to expand its growing presence in life sciences by investing further in knowledge, talent, partnerships, and ...

The trio worked together at Womble Bond Dickinson and bring significant intellectual property knowledge to Honigman as the ...